Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
This study has been completed.
Study NCT00295178   Information provided by Cubist Pharmaceuticals
First Received: February 21, 2006   Last Updated: December 14, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cellulitis
Additional conditions recognized in this trial
Erysipelas
More general conditions related to this trial
Bacterial Infections
Connective Tissue Diseases
Gram-Positive Bacterial Infections
Infection
Inflammation
Pathologic Processes
Skin Diseases
Skin Diseases, Bacterial
Skin Diseases, Infectious
Streptococcal Infections
Suppuration
Interventions listed in this trial
Daptomycin
Vancomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cubist Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services